NASDAQ
BioMarin Pharmaceutical Inc. (BMRN) has a free cash flow growth of 238.97% as of Friday, May 29, 2026. This represents a 4311.81% increase compared to its 12-month average of 5.42%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.